Lam Angela Y, Gonsalves Nirmala
Department of Gastroenterology and Hepatology, Kaiser Permanente San Francisco, San Francisco, California.
Division of Gastroenterology and Hepatology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois.
Gastroenterol Hepatol (N Y). 2025 Aug;21(8):511-519.
For eosinophilic esophagitis (EoE), the most well researched of the eosinophilic gastrointestinal diseases (EGIDs), there is a plethora of knowledge for its diagnosis and management; however, much less guidance is available for the non-EoE EGIDs. Efforts have been made to characterize the clinical features, epidemiology, diagnosis, and natural history of EGIDs, as the frequency of the non-EoE EGIDs has continued to rise. The diagnosis of the different non-EoE EGIDs, eosinophilic gastritis, enteritis, and colitis, can be challenging because of their rarity and heterogeneous presentations which can lead to delayed diagnosis and poor health-related quality of life in affected patients. Guidelines for histologic evaluation and diagnostic criteria for non-EoE EGID are actively being developed. Effective management of non-EoE EGIDs is possible with currently available assessments and therapies, with more treatments on the horizon, highlighting the need for improved understanding of non-EoE EGIDs. This article will review the diagnosis and management of the non-EoE EGIDs, focusing on the consensus nomenclature, nuances in diagnosis, and management options.
Gastroenterol Hepatol (N Y). 2025-8
Clin Gastroenterol Hepatol. 2024-7
Curr Opin Pediatr. 2024-12-1
Am J Gastroenterol. 2023-2-1
Gastro Hep Adv. 2025-1-25
Gastro Hep Adv. 2025-1-25
Gastroenterology. 2025-7
J Allergy Clin Immunol Pract. 2024-6
J Pediatr Gastroenterol Nutr. 2024-1
Am J Gastroenterol. 2024-7-1
Clin Transl Gastroenterol. 2024-1-1
Pediatr Allergy Immunol. 2023-6
Lancet Gastroenterol Hepatol. 2023-9